Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AWL-II-38.3 is a highly effective inhibitor of EphA3, a receptor for ephrin-A. It demonstrates potent kinase inhibitory activity against EphA3 and does not show significant cellular activity against Src-family kinases or b-raf [1] [2].
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 723 | 现货 | ||
5 mg | ¥ 1,820 | 现货 | ||
10 mg | ¥ 2,750 | 现货 | ||
25 mg | ¥ 4,590 | 现货 | ||
50 mg | ¥ 6,530 | 现货 | ||
100 mg | ¥ 8,920 | 现货 | ||
500 mg | ¥ 17,870 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 1,790 | 现货 |
产品描述 | AWL-II-38.3 is a highly effective inhibitor of EphA3, a receptor for ephrin-A. It demonstrates potent kinase inhibitory activity against EphA3 and does not show significant cellular activity against Src-family kinases or b-raf [1] [2]. |
体外活性 | AWL-II-38.3 fits to LIMK2 and LIMK1 ATP-binding and substrate-binding pockets [2] . |
分子量 | 469.42 |
分子式 | C23H18F3N5O3 |
CAS No. | 1135205-94-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 65 mg/mL (138.47 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.1303 mL | 10.6514 mL | 21.3029 mL | 53.2572 mL |
5 mM | 0.4261 mL | 2.1303 mL | 4.2606 mL | 10.6514 mL | |
10 mM | 0.213 mL | 1.0651 mL | 2.1303 mL | 5.3257 mL | |
20 mM | 0.1065 mL | 0.5326 mL | 1.0651 mL | 2.6629 mL | |
50 mM | 0.0426 mL | 0.213 mL | 0.4261 mL | 1.0651 mL | |
100 mM | 0.0213 mL | 0.1065 mL | 0.213 mL | 0.5326 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
AWL-II-38.3 1135205-94-5 Tyrosine Kinase/Adaptors Ephrin Receptor inhibit AWL II 38.3 LIMK1 Inhibitor LIMK2 EphA3 ATP AWLII38.3 inhibitor